Home Parker

Parker

acquired
IPO
Pharmaceutical R&D Developer

Basic Information

Kyowa Hakko Kirin Co., Ltd. is engaged in the manufacturing and sales of medical products and pharmaceuticals in the fields of nephrology, oncology, and immunology treatments. Its pharmaceutical products include: GRAN, a protein that facilitates rapid recovery from neutropenia and reduces infection risk; NESP, a drug for correcting anemia; ESPO, a glycoprotein used as a treatment for anemia relief in dialysis patients; and CONIEL, a calcium antagonist used for hypertension and angina pectoris.
Kyowa Kirin Co., Ltd.
Tokyo,Tokyo,Japan
more than 500 people
July 01, 1949
--